Geier Asset Management’s AbbVie ABBV Stock Holding History

Geier Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$588K	Buy	5,218 +99	+2%	+$11.2K	0.41%	53
2021 Q1	$587K	Buy	5,119 +760	+17%	+$81.3K	0.43%	52
2020 Q4	$470K	Buy	+4,359	New	+$419K	0.38%	53

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Geier Asset Management's ABBV Position: Q2 2021 in Review

Geier Asset Management increased its AbbVie (ABBV) stake by 1.9% in Q2 2021, buying an estimated $11.2K and bringing the position to 5,218 shares worth $588K. The position accounts for 0.41% of the portfolio, ranked #53.

Geier Asset Management first reported a position in ABBV in Q4 2020 and has held it in 3 quarters since. 2,677 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

Geier Asset Management held 5,218 shares of AbbVie worth $588K as of Q2 2021.
Geier Asset Management bought 99 AbbVie shares in Q2 2021, an estimated $11.2K.
AbbVie made up 0.41% of Geier Asset Management's portfolio in Q2 2021, its #53 holding.
Geier Asset Management first reported a position in AbbVie in Q4 2020 and has held it in 3 quarters since.
2,677 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Geier Asset Management's 13F filing for Q2 2021, filed 12 Jul 2021.